Table 6 Correlation between PFS and clinical-pathological data in a univariate analysis
5 years-PFS (%) | 95%CI | p | |
|---|---|---|---|
Age | 0.1 | ||
< 50 | 82 | 0.75–0.88 | |
≥ 50 | 75 | 0.67–0.81 | |
VD level | 0.2 | ||
< 20 ng/mL | 76 | 0.67–0.82 | |
≥ 20 ng/mL | 80 | 0.73–0.85 | |
Clinical stage | 0.00001 | ||
I-II | 84 | 0.78–0.89 | |
III | 62 | 0.51–0.72 | |
pCR | 0.0002 | ||
no | 72 | 0.65–0.78 | |
yes | 92 | 0.84–0.96 | |
Tumor subtypes | 0.00001 | ||
HER2+ | 84 | 0.74–0.90 | |
HR+/HER2- | 84 | 0.77–0.90 | |
TNBC | 62 | 0.51–0.72 | |
SBR grade | 0.3 | ||
II | 79 | 0.71–0.85 | |
III | 78 | 0.71–0.84 |